MicrobiologyAntimicrobial Agents and ChemotherapyPeer-reviewed
Frequent emergence of resistance mutations following complex intra-host genomic dynamics in SARS-CoV-2 patients receiving Sotrovimab
R. P. Cabrera, F. Tejerina, A. M. Salinas…·L. Perez-Lago
This study tracks resistance mutation emergence in SARS-CoV-2 patients treated with Sotrovimab, finding 68% resistance in BA.5 lineage with rapid onset and complex mutation dynamics.
DOI 10.1128/aac.00266-23